Since RBPs are known to regulate alternative splicing during human tissue development, we inspected the RNA expression levels of RBPs that have been linked to DM1 pathophysiology, i.e. those of the MBNL and CELF families, throughout development and in the disease situation (7,14). The gene discussed is CEBPD; the disease is myotonic dystrophy type 1.